TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF- B-Responsive Long Terminal Repeat Elements

Innate Immune Signaling Induces High Levels of TC-specific Deaminase Activity in Primary Monocyte-derived Cells through Expression of APOBEC3A Isoforms

(2010) Beth K. Thielen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of TRIM22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 Infection

(2010) R. Singh et al.   JOURNAL OF VIROLOGY

RNA-mediated displacement of an inhibitory snRNP complex activates transcription elongation

(2010) Iván D'Orso et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Antiviral Activity of the Interferon-Induced Cellular Protein BST-2/Tetherin

(2009) Andrey Tokarev et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5α and 22

(2009) Anna Kajaste-Rudnitski et al.   AMINO ACIDS

Human cellular restriction factors that target HIV-1 replication

(2009) Klaus Strebel et al.   BMC Medicine

Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells

(2009) David Perez-Caballero et al.   CELL

Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies

(2009) Gayathri Sivaramakrishnan et al.   EXPERIMENTAL CELL RESEARCH

The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase

(2009) Jessica Petersson et al.   EXPERIMENTAL CELL RESEARCH

B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies

(2009) Gayathri Sivaramakrishnan et al.   FEBS LETTERS

Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain

(2009) Bo Gao et al.   HEPATOLOGY

Different subcellular localisations of TRIM22 suggest species-specific function

(2009) Anna-Maria Herr et al.   IMMUNOGENETICS

Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components

(2009) Martha R. Neagu et al.   JOURNAL OF CLINICAL INVESTIGATION

TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus

(2009) P. Eldin et al.   JOURNAL OF GENERAL VIROLOGY

TRIM21 Is Essential to Sustain IFN Regulatory Factor 3 Activation during Antiviral Response

(2009) K. Yang et al.   JOURNAL OF IMMUNOLOGY

Human TRIM5α Expression Levels and Reduced Susceptibility to HIV‐1 Infection

(2009) Shamman Sewram et al.   JOURNAL OF INFECTIOUS DISEASES

A B-Box 2 Surface Patch Important for TRIM5  Self-Association, Capsid Binding Avidity, and Retrovirus Restriction

(2009) F. Diaz-Griffero et al.   JOURNAL OF VIROLOGY

Embryonic stem cells use ZFP809 to silence retroviral DNAs

(2009) Daniel Wolf et al.   NATURE

Human TRIM Gene Expression in Response to Interferons

(2009) Laetitia Carthagena et al.   PLoS One

Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies

(2009) Laurence Colin et al.   Retrovirology

Trim11 increases expression of dopamine β-hydroxylase gene by interacting with Phox2b

(2008) Seok Jong Hong et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Identification of TRIM22 as a RING finger E3 ubiquitin ligase

(2008) Zhijian Duan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Interferon-α enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models

(2008) Shigeto Kawai et al.   CANCER SCIENCE

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

(2008) Stuart J. D. Neil et al.   NATURE

Crystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer Element

(2008) Darren L. Bates et al.   STRUCTURE

The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22

(2008) Stephen D. Barr et al.   PLoS Pathogens